| Cervical
cancer
Cancer of the uterine cervix can be detected very early in its
oncogenesis. Oncogenesis is the medical term meaning the process
of promoting and progressing to full fledged cancer. When detected
early usually by Papanicolaou (Pap) smear, it is curable.
It is now proven that cancer of cervix is caused by human
papilloma virus (HPV). Other associative factors are coitus at an
early age, many sexual partners, genital herpesvirus infections,
multiparity, and poor obstetric and gynecologic care. These
patients have higher incidence of HPV infections. Early cervical
cancer has no symptom, but there may be a watery vaginal discharge
or occasional spotting of blood. Late cancer of cervix may cause a
dark, foul-smelling vaginal discharge, leakage from bladder or
rectal fistulas, anorexia, weight loss, and back and leg pains
depending on which patho-physiological sites are affected In
addition, patients with advanced cancer of cervix may have
symptoms and signs of para-neoplastic complications.
Pap smears of cervical cells are highly important in screening.
Confirmatory diagnoses are based on colposcopic examination and
cytologic study of specimens obtained by biopsy. Suitable sites
for biopsy may be indicated by applying 3% acetic acid to the
cervix to accentuate characteristic changes in neoplastic
epithelium or by using Schiller's test in which an iodine solution
stains normal cervical cells dark brown and does not stain the
nonglycogen-producing cells of malignant epithelium. Cervical
dysplasia may regress, persist, or progress to clinical disease,
but carcinoma in situ is considered to be a precursor of invasive
carcinoma. About 90% of cervical cancers are squamous cell
carcinomas, fewer than 10% are adenocarcinomas, and others are
mixtures of these kinds, or, in rare cases, sarcomas. Cancers on
the surface of the cervix may be huge, polypoid masses whereas
endophytic lesions tend to be small and hard; ulcerative lesions
may cause extensive erosion. Cervical cancer invades the tissues
of adjacent organs and may spread through lymphatic channels to
distant sites, including the lungs, bone, liver, brain, and
para-aortic nodes. Treatment depends on the kind and the extent of
the malignancy, the age of the woman, and her general health. Also
considered are her wishes in regard to maintaining her
reproductive function. Carcinoma in situ may be treated by
excisional conization or cryosurgery. Invasive tumors may be
treated with radium implants or with radiotherapy or vaginal or
abdominal hysterectomy. Radical hysterectomy is an American
invention. It is a accepted palliative approach in modern
medicine.
A new vaccine is now available. This quadrivalent vaccine known
as Gardasil, is marketed by Merck Pharmaceuticals. This
vaccine protects girls against four subtypes of human papilloma
virus.
If you have questions related to this article you
may e-mail me at doctor@soontongkiong.com quoting the contents of
the article.
About the author
DR SOON is a medical practitioner. He holds four degrees. MBBS
(University of Malaya), MBA (University of East Asia), LLB (Hons)
(University of Wolverhampton), Master of Medicine (Edith Cowan
University)
|